ES2160714T3 - Analisis y dispositivos para la deteccion de atresia biliar extrahepatica. - Google Patents

Analisis y dispositivos para la deteccion de atresia biliar extrahepatica.

Info

Publication number
ES2160714T3
ES2160714T3 ES95932298T ES95932298T ES2160714T3 ES 2160714 T3 ES2160714 T3 ES 2160714T3 ES 95932298 T ES95932298 T ES 95932298T ES 95932298 T ES95932298 T ES 95932298T ES 2160714 T3 ES2160714 T3 ES 2160714T3
Authority
ES
Spain
Prior art keywords
devices
detection
extrahepatic
atresia
biliar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95932298T
Other languages
English (en)
Inventor
Laszlo Takacs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of ES2160714T3 publication Critical patent/ES2160714T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2337/00—N-linked chromogens for determinations of peptidases and proteinases
    • C12Q2337/10—Anilides
    • C12Q2337/12—Para-Nitroanilides p-NA
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCION IMPLICA UNA VARIEDAD DE METODOS Y DISPOSITIVOS DE ENSAYO PARA INVESTIGAR O DIAGNOSTICAR LA APARICION DE ATRESIA BILIAR EXTRAHEPATICA. EN PARTICULAR, LOS METODOS Y DISPOSITIVOS IMPLICAN LA DETECCION DE DIPEPTIDIL PEPTIDASA IV EN UNA MUESTRA DE ENSAYO COMO INDICADORA DE LA ATRESIA BILIAR EXTRAHEPATICA.
ES95932298T 1994-07-14 1995-07-13 Analisis y dispositivos para la deteccion de atresia biliar extrahepatica. Expired - Lifetime ES2160714T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/275,887 US5601986A (en) 1994-07-14 1994-07-14 Assays and devices for the detection of extrahepatic biliary atresia

Publications (1)

Publication Number Publication Date
ES2160714T3 true ES2160714T3 (es) 2001-11-16

Family

ID=23054238

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95932298T Expired - Lifetime ES2160714T3 (es) 1994-07-14 1995-07-13 Analisis y dispositivos para la deteccion de atresia biliar extrahepatica.

Country Status (10)

Country Link
US (1) US5601986A (es)
EP (1) EP0820522B1 (es)
AT (1) ATE205884T1 (es)
AU (1) AU3538195A (es)
CA (1) CA2187783C (es)
DE (1) DE69522831T2 (es)
DK (1) DK0820522T3 (es)
ES (1) ES2160714T3 (es)
PT (1) PT820522E (es)
WO (1) WO1996002667A1 (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020086399A1 (en) * 1996-02-29 2002-07-04 Fuji Photo Film Co., Ltd. Method of measurement of protease and thin membranes used for said method
US6235493B1 (en) * 1997-08-06 2001-05-22 The Regents Of The University Of California Amino acid substituted-cresyl violet, synthetic fluorogenic substrates for the analysis of agents in individual in vivo cells or tissue
JP4887139B2 (ja) * 2003-03-25 2012-02-29 武田薬品工業株式会社 ジペプチジルペプチダーゼインヒビター
EP1625122A1 (en) 2003-05-14 2006-02-15 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
US7678909B1 (en) 2003-08-13 2010-03-16 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US7169926B1 (en) 2003-08-13 2007-01-30 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
DE602004010206T2 (de) * 2003-08-13 2008-10-09 Takeda Pharmaceutical Co. Ltd. Dipeptidyl Peptidase Inhibitoren.
EP1697342A2 (en) * 2003-09-08 2006-09-06 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
JP2007505121A (ja) * 2003-09-08 2007-03-08 武田薬品工業株式会社 ジペプチジルぺプチダーゼ阻害剤
US7732446B1 (en) 2004-03-11 2010-06-08 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
CA2559302C (en) * 2004-03-15 2012-06-19 Takeda Pharmaceutical Company Limited 6-amino-1h-pyrimidine-2,4-dione derivatives as dipeptidyl peptidase inhibitors
US7687638B2 (en) * 2004-06-04 2010-03-30 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
WO2006019965A2 (en) 2004-07-16 2006-02-23 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
US20060019406A1 (en) * 2004-07-23 2006-01-26 Ning Wei Lateral flow device for the detection of large pathogens
US20060068500A1 (en) * 2004-09-28 2006-03-30 Kimberly-Clark Worldwide, Inc. Detecting yeast infections using a lateral flow assay
JP2008524331A (ja) * 2004-12-21 2008-07-10 武田薬品工業株式会社 ジペプチジルペプチダーゼ阻害剤
US8506934B2 (en) 2005-04-29 2013-08-13 Robert I. Henkin Methods for detection of biological substances
WO2007033266A2 (en) * 2005-09-14 2007-03-22 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors for treating diabetis
WO2007033265A1 (en) * 2005-09-14 2007-03-22 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors for treating diabetis
PT1942898E (pt) * 2005-09-14 2011-12-20 Takeda Pharmaceutical Inibidores da dipeptidilpeptidase para o tratamento da diabetes
JP5122462B2 (ja) * 2005-09-16 2013-01-16 武田薬品工業株式会社 ジペプチジルペプチダーゼ阻害剤
TW200745079A (en) * 2005-09-16 2007-12-16 Takeda Pharmaceuticals Co Polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor
TW200745080A (en) * 2005-09-16 2007-12-16 Takeda Pharmaceuticals Co Polymorphs of tartrate salt of 2-[2-(3-(R)-amino-piperidin-1-yl)-5-fluoro-6-oxo-6H-pyrimidin-1-ylmethyl]-benzonitrile and methods of use therefor
GB2435512A (en) * 2006-02-23 2007-08-29 Mologic Ltd A binding assay and assay device
GB2435510A (en) 2006-02-23 2007-08-29 Mologic Ltd Enzyme detection product and methods
GB2435511A (en) * 2006-02-23 2007-08-29 Mologic Ltd Protease detection
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
WO2007112368A1 (en) * 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Preparation of (r)-3-aminopiperidine dihydrochloride
GB0606822D0 (en) 2006-04-05 2006-05-17 Alaska Food Diagnostics Assay System
GB2437311A (en) * 2006-04-07 2007-10-24 Mologic Ltd A protease detection product
US8324383B2 (en) 2006-09-13 2012-12-04 Takeda Pharmaceutical Company Limited Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
KR102062824B1 (ko) * 2006-09-13 2020-01-07 다케다 야쿠힌 고교 가부시키가이샤 2-［6-(3-아미노-피페리딘-1-일)-3-메틸-2,4-디옥소-3,4-디하이드로-2ｈ-피리미딘-1-일메틸］-4-플루오로-벤조니트릴의 용도
TW200838536A (en) * 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
US8293489B2 (en) 2007-01-31 2012-10-23 Henkin Robert I Methods for detection of biological substances
US8093236B2 (en) 2007-03-13 2012-01-10 Takeda Pharmaceuticals Company Limited Weekly administration of dipeptidyl peptidase inhibitors
US8580801B2 (en) 2008-07-23 2013-11-12 Robert I. Henkin Phosphodiesterase inhibitor treatment
CN102818866B (zh) * 2012-08-03 2014-01-22 上海交通大学医学院附属新华医院 用于新生儿胆道闭锁的诊断标记物的应用
US10598672B2 (en) 2014-02-18 2020-03-24 Cyrano Therapeutics, Inc. Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell
WO2017009214A1 (en) * 2015-07-10 2017-01-19 INSERM (Institut National de la Santé et de la Recherche Médicale) Early and non invasive method for assessing a subject's risk of having a papillon-lefevre syndrome
US20190145981A1 (en) 2016-04-21 2019-05-16 Sphingotec Therapeutics Gmbh Methods for determining dpp3 and therapeutic methods
US20230097988A1 (en) 2020-02-26 2023-03-30 Pam Theragnostics Gmbh Methods for determining peptidylglycine alpha-amidating monooxygenase (pam) and its use for diagnostic purpose
CN115243709A (zh) 2020-02-26 2022-10-25 Pam治疗诊断有限公司 肽酰甘氨酸α-酰胺化单加氧酶(PAM)用于治疗目的的用途
CN117288962A (zh) * 2023-10-09 2023-12-26 广州市妇女儿童医疗中心 检测标志物组合的试剂在制备胆道闭锁诊断产品中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4191808A (en) * 1975-10-30 1980-03-04 Ajinomoto Co., Inc. Method of measuring dipeptidyl-amino-peptidase activity
US4191809A (en) * 1977-02-26 1980-03-04 Ajinomoto Co., Inc. Method of measuring enzymatic activity using novel peptide derivatives
US4361537A (en) * 1979-01-12 1982-11-30 Thyroid Diagnostics, Inc. Test device and method for its use
US4299916A (en) * 1979-12-26 1981-11-10 Syva Company Preferential signal production on a surface in immunoassays
US5122602A (en) * 1989-02-13 1992-06-16 Miles Inc. Chromogenic merocyanine enzyme substrates

Also Published As

Publication number Publication date
AU3538195A (en) 1996-02-16
EP0820522B1 (en) 2001-09-19
CA2187783A1 (en) 1996-02-01
EP0820522A1 (en) 1998-01-28
DK0820522T3 (da) 2001-11-19
PT820522E (pt) 2002-02-28
ATE205884T1 (de) 2001-10-15
DE69522831D1 (de) 2001-10-25
CA2187783C (en) 2000-02-08
DE69522831T2 (de) 2002-04-04
US5601986A (en) 1997-02-11
WO1996002667A1 (en) 1996-02-01

Similar Documents

Publication Publication Date Title
ES2160714T3 (es) Analisis y dispositivos para la deteccion de atresia biliar extrahepatica.
BG104275A (en) Method and device for express analysis of tested parameters in biological samples
BR9711869B1 (pt) mÉtodo e kit para coletar amostras de espÉcimes lÍquidas para teste analÍtico.
DE69836888D1 (de) Verfahren für Fluoreszenzerkennungstest
ES2157220T3 (es) Aparato de ensayo analitico con control negativo y positivo incorporado.
ATE217190T1 (de) Test und reagentien zur identifizierung von antiproliferierenden stoffen
DE60031939D1 (de) Als Quelle und Responder betreibbare ATM-Prüfvorrichtung zur Ausführung von mehreren Tests
ATE232559T1 (de) Verfahren zur signalverstärkung
GB9804083D0 (en) Immunoassays
CY1105025T1 (el) Αναλυση λεπτινης βασιζομενη στην ανιχνευση εκφρασης ang-2
BR9708421A (pt) Processo para a deteccão de doenca provocada por prions teste diagnostico ou kit de teste e uso do processo
ES2154736T3 (es) Metodo de analisis.
PT918991E (pt) Metodo de ensaio
MX9706437A (es) Proceso y compuestos para la deteccion de analitos usando medicion de remanencia y el uso de los mismos.
DE69332084D1 (de) Eine petroleum immuntestmethode und ihre komponenten
DE69724515D1 (de) Vorrichtung und Testsatz zum Test von Serum und dergleichen
CY1106705T1 (el) Δοκιμασια για μετρηση ολο-τρανσκοβαλαμινης και φολικου
PT1190245E (pt) Deteccao de alergenos
ATE208040T1 (de) Immunoassay-reagenzien, testsätze und verfahren
ATE274702T1 (de) Verwendung derivatisierter reagenzien in chemilumineszenz- und elektrochemilumineszenz- nachweisverfahren
ATE377191T1 (de) Verfahren zur analyse von stuhlproben für diagnostische zwecke
WO1999027366A3 (en) Method of detecting prostate specific antigen activation peptide
ATE278193T1 (de) Verfahren zum testen eines asialoglycoproteinrezeptors und testreagenz dafür
ATE347108T1 (de) Zusammensetzungen und verfahren zum bestimmen von aa4rp
ITRM980754A0 (it) Metodo per la misurazione di un analita in condizioni non isoterme e apparato biosensore per la sua esecuzione

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 820522

Country of ref document: ES